Analytical methods for assessing exposure to 4-aminobiphenyl based on protein adduct formation. 1986

P L Skipper, and M S Bryant, and S R Tannenbaum, and J D Groopman

Past studies with animals have demonstrated that 4-aminobiphenyl (ABP) administration results in the formation of appreciable amounts of adducts between the carcinogen and both serum albumin and hemoglobin. The hemoglobin adduct is relatively stable in vivo, but may be readily hydrolyzed in vitro to regenerate ABP. The formation of this adduct reflects a mixed-function oxidase-mediated metabolic pathway operating directly on the amine. The predominant albumin adduct, 3-(tryptophan-N1-yl)-4-acetylaminobiphenyl, reflects the contribution of N-acetyltransferase activity as well as mixed function oxidase activity to the overall metabolism. The simultaneous measurement of these two different adducts thus offers an opportunity to investigate the role of both ABP and acetylator phenotype in bladder carcinogenesis. An analytical method, using gas chromatography coupled with electron capture detection, was developed to quantitate ABP adducted to hemoglobin.

UI MeSH Term Description Entries
D008297 Male Males
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002274 Carcinogens, Environmental Carcinogenic substances that are found in the environment. Environmental Carcinogens
D002849 Chromatography, Gas Fractionation of a vaporized sample as a consequence of partition between a mobile gaseous phase and a stationary phase held in a column. Two types are gas-solid chromatography, where the fixed phase is a solid, and gas-liquid, in which the stationary phase is a nonvolatile liquid supported on an inert solid matrix. Chromatography, Gas-Liquid,Gas Chromatography,Chromatographies, Gas,Chromatographies, Gas-Liquid,Chromatography, Gas Liquid,Gas Chromatographies,Gas-Liquid Chromatographies,Gas-Liquid Chromatography
D004781 Environmental Exposure The exposure to potentially harmful chemical, physical, or biological agents in the environment or to environmental factors that may include ionizing radiation, pathogenic organisms, or toxic chemicals. Exposure, Environmental,Environmental Exposures,Exposures, Environmental
D006454 Hemoglobins The oxygen-carrying proteins of ERYTHROCYTES. They are found in all vertebrates and some invertebrates. The number of globin subunits in the hemoglobin quaternary structure differs between species. Structures range from monomeric to a variety of multimeric arrangements. Eryhem,Ferrous Hemoglobin,Hemoglobin,Hemoglobin, Ferrous
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000611 Aminobiphenyl Compounds Biphenyl compounds substituted in any position by one or more amino groups. Permitted are any substituents except fused rings. Biphenylamines,Compounds, Aminobiphenyl
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

P L Skipper, and M S Bryant, and S R Tannenbaum, and J D Groopman
August 2010, Inhalation toxicology,
P L Skipper, and M S Bryant, and S R Tannenbaum, and J D Groopman
January 1990, Progress in clinical and biological research,
P L Skipper, and M S Bryant, and S R Tannenbaum, and J D Groopman
June 2011, Chemical research in toxicology,
P L Skipper, and M S Bryant, and S R Tannenbaum, and J D Groopman
November 2001, Bulletin of environmental contamination and toxicology,
P L Skipper, and M S Bryant, and S R Tannenbaum, and J D Groopman
November 2010, Analytical and bioanalytical chemistry,
P L Skipper, and M S Bryant, and S R Tannenbaum, and J D Groopman
November 2018, Cancer medicine,
P L Skipper, and M S Bryant, and S R Tannenbaum, and J D Groopman
August 2003, Journal of the National Cancer Institute,
P L Skipper, and M S Bryant, and S R Tannenbaum, and J D Groopman
January 2014, Frontiers in pharmacology,
P L Skipper, and M S Bryant, and S R Tannenbaum, and J D Groopman
January 1999, The Journal of nutrition,
P L Skipper, and M S Bryant, and S R Tannenbaum, and J D Groopman
January 1999, Chemical research in toxicology,
Copied contents to your clipboard!